House2025-26 session

ESHB 2196 — Expanding access to PANDA PANS treatment.

Did not pass — the 2025–26 session has ended

Sponsor
Simmons
Introduced
February 3, 2026
Status
H Rules 3C
Last action
By resolution, returned to House Rules Committee for third reading. (March 12, 2026)

What this bill does

Requires private fully insured health plans to provide coverage of three monthly immunomodulatory courses of intravenous immunoglobulin therapy for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS) if certain conditions are met.

From the Washington State Legislature's nonpartisan staff bill analysis. Read the full analysis ↗

Floor votes

  • House — 3rd Reading & Final Passage · February 16, 2026
    83 yea · 13 nay · 2 not voting

Track ESHB 2196 on OlympiaTrack

A free account adds a plain-English AI summary, the full hearing and amendment record, who testified, and roll calls by member. Track the subject and get an alert if it comes back next session.

Create a free account

Other bills sponsored by Simmons

All 2025-26 Washington State bills →

Source: the Washington State Legislature. OlympiaTrack is an independent bill-tracking service and is not affiliated with the Legislature. View on leg.wa.gov ↗